Search results

Evidence-based recommendations on elbasvir–grazoprevir (Zepatier) for treating genotype 1 or 4 chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

26 October 2016

Evidence-based recommendations on sofosbuvir (Sovaldi) for treating some types of chronic hepatitis C (HCV)

Result type

Technology appraisal guidance

Published

25 February 2015

Evidence-based recommendations on peginterferon alfa (Pegasys; ViraferonPeg) and ribavirin (Copegus) for treating chronic hepatitis C in children and young people.

Result type

Technology appraisal guidance

Published

27 November 2013

Evidence-based recommendations on sofosbuvir–velpatasvir (Epclusa) for treating chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

25 January 2017

Boceprevir is no longer available in the UK so this guidance has been withdrawn.

Result type

Technology appraisal guidance

Published

25 April 2012

Evidence-based recommendations on ombitasvir–paritaprevir–ritonavir (also known as Viekirax) with or without dasabuvir (also known as Exviera) for adults with some types (called genotypes) of chronic hepatitis C.

Result type

Technology appraisal guidance

Published

25 November 2015

Evidence-based recommendations on ledipasvir–sofosbuvir (Harvoni) for treating some types (genotypes) of chronic hepatitis C

Result type

Technology appraisal guidance

Published

25 November 2015